NFIB and liver cancer: Moreover, urea cycle enzymes (ASS1 and CPS1) are inhibited in liver cancer (Kim et al., 2021; Ridder et al., 2021), so the expression of them have decreased in liver cancer cells, and the increase of ASS1 and CPS1 caused by knocking down NFIB becomes insignificant.